Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Kang S et al. | Altered levels of α-synuclein and sphingolipids in Batten disease lymphoblast cells. | 2014 | Gene | pmid:24534465 |
Jaishree G and Sharmila DJ | Molecular dynamics study of the conformations of glycosidic linkages in sialic acid modified ganglioside GM3 analogues. | 2014 | Glycoconj. J. | pmid:24909815 |
Lukina E et al. | Eliglustat, an investigational oral therapy for Gaucher disease type 1: Phase 2 trial results after 4 years of treatment. | 2014 | Blood Cells Mol. Dis. | pmid:24835462 |
Chung TW et al. | The ganglioside GM3 is associated with cisplatin-induced apoptosis in human colon cancer cells. | 2014 | PLoS ONE | pmid:24829158 |
Alfonso S et al. | A randomized, multicenter, placebo-controlled clinical trial of racotumomab-alum vaccine as switch maintenance therapy in advanced non-small cell lung cancer patients. | 2014 | Clin. Cancer Res. | pmid:24788102 |
Huang Q et al. | A new liquid chromatography/tandem mass spectrometry method for quantification of gangliosides in human plasma. | 2014 | Anal. Biochem. | pmid:24680754 |
Lee H et al. | Inhibition of GM3 synthase attenuates neuropathology of Niemann-Pick disease Type C. by affecting sphingolipid metabolism. | 2014 | Mol. Cells | pmid:24599001 |
Qu H et al. | Synthesis and cytotoxicity assay of four ganglioside GM3 analogues. | 2014 | Eur J Med Chem | pmid:24534540 |
Inokuchi J | GM3 and diabetes. | 2014 | Glycoconj. J. | pmid:24399479 |
Wang XQ et al. | Ganglioside GM3 depletion reverses impaired wound healing in diabetic mice by activating IGF-1 and insulin receptors. | 2014 | J. Invest. Dermatol. | pmid:24326453 |